Articles - Page 2 of 84 - Drugs in Context

Clinical experience with pemigatinib for previously treated metastatic cholangiocarcinoma: practical considerations from clinical cases

Jonathan Wadsley, Alan Christie, Roopinder Gillmore, Amy Trinh, Rachel Greig

Article Type

Case Series

Published

14 Aug 2023

Three clinical cases are presented in this article to illustrate the position of pemigatinib in the management of cholangiocarcinoma and related toxicities.

META-INSTI: metabolic adverse events following integrase strand transfer inhibitor administration in spontaneous adverse event reports

Milena M Murray, Lara Fakhouri, Spencer E Harpe

Article Type

Original Research

Published

09 Aug 2023

This study evaluates the relationship between integrase strand transfer inhibitors and metabolic adverse events using the FDA Adverse Event Reporting System database.

Use of immunomodulatory therapy as part of comprehensive treatment of non-severe community-acquired pneumonia and its long-term results

Mikhail P Kostinov, Vilia V Gainitdinova, Svetlana V Kazharova, Anna E Vlasenko, Vflentina B Polishchuk, Kirill V Mashilov

Article Type

Original Research

Published

08 Aug 2023

This work aims to study the effectiveness of two different types of immunomodulators for the treatment of non-severe community-acquired pneumonia and assesses the long-term effects of the treatment conducted.

The treatment of mild upper respiratory tract infections – a position paper with recommendations for best practice

Andrew Smith, Peter Kardos, Oliver Pfaar, Winfried Randerath, Guillermo Estrada Riolobos, Fulvio Braido, Laura Sadofsky

Article Type

Review

Published

25 Jul 2023

This position paper addresses the treatment of mild upper respiratory tract infections (MURTIs) and provides recommendations for best practice.

Dietary therapy for patients with chronic pancreatitis in Japan: a cross-sectional online survey of physicians and registered dietitians

Yuko Hasebe, Yusuke Karasawa, Kazutaka Nozawa

Article Type

Original Research

Published

24 Jul 2023

This study was aimed towards understanding the current status of dietary therapy for patients with pancreatic exocrine insufficiency in Japan and its alignment with Japanese recommendations for high-fat intake and concomitant high-potency pancreatic enzyme replacement therapy by surveying treating physicians and registered dietitians.